The DOI matches its Crossref record; 249 of the 249 references it cites were found in a registry or an index.
Cancer immune evasion, immunoediting and intratumour heterogeneity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–249 of 249
Lo, J. A., Kawakubo, M., Juneja, V. R., Su, M. Y., Erlich, T. H., LaFleur, M. W., Kemeny, L. V., Rashid, M., Malehmir, M., Rabi, S. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8636 · Cited by 97 · cited 1×
“Subclonal antigen expression also limits the potential benefits of tumour antigen spreading 194,195 .”
Holm, J. S., Funt, S. A., Borch, A., Munk, K. K., Bjerregaard, A.-M., Reading, J. L., Maher, C. A., Regazzi, A. M., Wong, P., Al‐Ahmadie, H. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29342-0 · Cited by 95
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00505-0 · Cited by 93
Verronèse, E., Delgado, A. S., Valladeau‐Guilemond, J., Garin, G., Guillemaut, S., Trédan, O., Ray-Coquard, I., Bachelot, T., Nkodia, A., Bardin-dit-Courageot, C., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1100791 · Cited by 92
Lack of detectable neoantigen depletion signals in the untreated cancer genome
den Eynden, J. V., Jiménez-Sánchez, A., Miller, M. L., & Larsson, E. (2019) · Nature Genetics · doi:10.1038/s41588-019-0532-6 · Cited by 92
Yang, B., Li, X., Zhang, W., Fan, J., Zhou, Y., Li, W., Yin, J., Yang, X., Guo, E., Li, X., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100856 · Cited by 84
HLA ANTIGENS IN OCULAR TISSUES
Abi‐Hanna, D., Wakefield, D., & Watkins, S. (1988) · Transplantation · doi:10.1097/00007890-198803000-00021 · Cited by 83
Chromosomal copy number heterogeneity predicts survival rates across cancers
van Dijk, E., van den Bosch, T., Lenos, K., Makrini, K. E., Nijman, L. E., Essen, H. F. H. V., Lansu, N. R., Boekhout, M., Hageman, J. H., Fitzgerald, R. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23384-6 · Cited by 79
Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors
Zapata, L., Caravagna, G., Williams, M. J., Lakatos, E., AbdulJabbar, K., Werner, B., Chowell, D., James, C. T., Gourmet, L. E., Milite, S., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01313-1 · Cited by 76
Ge, Q., Bai, A., Jones, B. T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307339101 · Cited by 69
Locally sourced: site-specific immune barriers to metastasis
Correia, A. L. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00836-2 · Cited by 65
Understanding specificity and sensitivity of T-cell recognition
George, A. J. T., Stark, J., & Chan, C. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.09.011 · Cited by 62
Tumor Endothelial Cell–Mediated Antigen-Specific T-cell Suppression via the PD-1/PD-L1 Pathway
Taguchi, K., Onoe, T., Yoshida, T., Yamashita, Y., Tanaka, Y., & Ohdan, H. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0897 · Cited by 62
Grasso, C. S., Tsoi, J., Onyshchenko, M. I., Abril-Rodríguez, G., Ross‐Macdonald, P., Wind‐Rotolo, M., Champhekar, A. S., Medina, E., Torrejon, D. Y., Shin, D. S., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.11.015 · Cited by 62
Kim, S.-H., Roszik, J., Cho, S.-N., Ogata, D., Milton, D. R., Peng, W., Menter, D. G., Ekmekçioglu, S., & Grimm, E. A. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1163 · Cited by 61
Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer
Zhou, J.-B., Min, Z., Zhang, D., Wang, W., Marincola, F., & Wang, X.-D. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0304-0 · Cited by 59
Inferring structural variant cancer cell fraction
Cmero, M., Yuan, K., Ong, C. S., Schröder, J., PCAWG Evolution and Heterogeneity Working Group, Adams, D. J., Anur, P., Beroukhim, R., Boutros, P. C., Bowtell, D. D. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14351-8 · Cited by 58
Weenink, B., Draaisma, K., Ooi, H. Z., Kros, J. M., Smitt, P. A. E. S., Debets, R., & French, P. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51063-6 · Cited by 57
Shinchi, Y., Ishizuka, S., Komohara, Y., Matsubara, E., Mito, R., Pan, C., Yoshii, D., Yonemitsu, K., Fujiwara, Y., Ikeda, K., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03187-4 · Cited by 57
Reed, C. M., Cresce, N. D., Mauldin, I. S., Slingluff, C. L., & Olson, W. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0233 · Cited by 55
Farrington, L. A., Smith, T. A., Grey, F. E., Hill, A. B., & Snyder, C. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203151 · Cited by 55
IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer
Wang, L., Miyahira, A. K., Simons, D. L., Lu, X., Chang, A. Y., Wang, C., Suni, M. A., Maino, V. C., Dirbas, F. M., Yim, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1373 · Cited by 55
Cheung, A. F., DuPage, M. J. P., Dong, H., Chen, J., & Jacks, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2634 · Cited by 51
Ataide, M. A., Knöpper, K., de Casas, P. C., Ugur, M., Eickhoff, S., Zou, M., Shaikh, H., Trivedi, A., Grafen, A., Yang, T., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.019 · Cited by 51
Once upon a prime: DCs shape cancer immunity
Zagorulya, M., & Spranger, S. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.10.006 · Cited by 49
Self-citationFailli, A., Legitimo, A., Orsini, G., Romanini, A., & Consolini, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.013 · Cited by 46
CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy
Huff, A. L., Longway, G., Mitchell, J. T., Andaloori, L., Davis-Marcisak, E. F., Chen, F., Lyman, M. R., Wang, R., Mathew, J., Barrett, B., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.174027 · Cited by 46
Tu, S., Bilen, M. A., Hess, K. R., Broaddus, R. R., Kopetz, S., Wei, C., Pagliaro, L. C., Karam, J. A., Ward, J. F., Wood, C. G., et al. (2016) · Cancer · doi:10.1002/cncr.29996 · Cited by 45
Feng, L., Qian, H.-P., Yu, X., Liu, K., Xiao, T., Zhang, C., Kuang, M., Cheng, S., Li, X., Wan, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05538-z · Cited by 45
BAYCLONE: BAYESIAN NONPARAMETRIC INFERENCE OF TUMOR SUBCLONES USING NGS DATA
Sengupta, S., WANG, J., Lee, J., Müller, P., Gulukota, K., Banerjee, A., & Ji, Y. (2014) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814644730_0044 · Cited by 40
Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, I. M., Kjær, L., Skov, V., Ellervik, C., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-018-0166-4 · Cited by 40
Desmoplastic Reaction, Immune Cell Response, and Prognosis in Colorectal Cancer
Akimoto, N., Väyrynen, J. P., Zhao, M. M., Ugai, T., Fujiyoshi, K., Borowsky, J., Zhong, R., Haruki, K., Arima, K., Lau, M. C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840198 · Cited by 39
Everybody needs good neighbours: the progressive DCIS microenvironment
Gibson, S. V., Roozitalab, R., Allen, M. D., Jones, J. L., Carter, E. P., & Grose, R. P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.002 · Cited by 38
Cancer-Testis Antigens and Immunotherapy in the Light of Cancer Complexity
Grizzi, F., Mirandola, L., Qehajaj, D., Cobos, E., Figueroa, J. A., & Chiriva‐Internati, M. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1018418 · Cited by 36
Xia, R., Xiao, J., Zhang, Y., Teng, H., Cheng, F., Chen, H., Zhang, K., & Sun, Z. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920977117 · Cited by 36
Michelakos, T. P., Kontos, F., Kurokawa, T., Cai, L., Sadagopan, A., Krijgsman, D., Weichert, W., Durrant, L. G., Kuppen, P. J. K., Ferrone, C. R., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004115 · Cited by 36
Adaptive Immunity Does Not Strongly Suppress Spontaneous Tumors in a Sleeping Beauty Model of Cancer
Rogers, L. M., Olivier, A. K., Meyerholz, D. K., & Dupuy, A. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203227 · Cited by 34
Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Diamond, M. S., Lin, J., & Vonderheide, R. H. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0785 · Cited by 30
Jiang, Q., Pan, H., Ye, D., Zhang, P., Zhong, L., & Zhang, Z. (2010) · Tumor Biology · doi:10.1007/s13277-010-0054-4 · Cited by 27
Pervasiveness of HLA allele-specific expression loss across tumor types
Filip, I., Wang, A., Kravets, O., Orenbuch, R., Zhao, J., Perea-Chamblee, T. E., Manji, G. A., de Maturana, E. L., Malats, N., Olive, K. P., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01154-x · Cited by 27
Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg Problem
Spranger, S. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.008 · Cited by 25
Self-citationThe immune phenotypes and different immune escape mechanisms in colorectal cancer
Mao, Y., Xu, Y., Jiang, C., Chang, W., Lv, Y., Zheng, P., Zhang, Z., Li, Z., Lin, Q., Tang, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968089 · Cited by 24
Nguyen, K. B., Roerden, M., Copeland, C., Backlund, C. M., Klop-Packel, N. G., Remba, T. K., Kim, B., Singh, N. K., Birnbaum, M. E., Irvine, D. J., et al. (2023) · eLife · doi:10.7554/elife.85263 · Cited by 22
Self-citationThe Effects of Clonal Heterogeneity on Cancer Immunosurveillance
Dijkstra, K. K., Wu, Y., & Swanton, C. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061521-101910 · Cited by 17
Torres-Mejia, E., Weng, S., Whittaker, C. A., Nguyen, K. B., Duong, E., Yim, L., & Spranger, S. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0184 · Cited by 17
Self-citationBoström, M., & Larsson, E. (2022) · Nature Communications · doi:10.1038/s41467-022-34746-z · Cited by 16
Neoantigen prediction from genomic and transcriptomic data
Battaglia, S. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.10.003 · Cited by 14
Wolf, S. P., Anastasopoulou, V., Drousch, K., Diehl, M. I., Engels, B., Yew, P. Y., Kiyotani, K., Nakamura, Y., Schreiber, K., Schreiber, H. W., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2905 · Cited by 13
Kaçar, Z., SLUD, E. V., Levy, D., Candia, J., Budhu, A., Forgues, M., Wu, X., Raziuddin, A., Tran, B. Q., Shetty, J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06040-9 · Cited by 9
Metadata
- Authors
- Roerden, M., & Spranger, S.
- Venue
- Nature Reviews Immunology
- Published
- 2025-01-02
- Volume
- 25
- Issue
- 5
- Pages
- 353-369
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W4405983094
- Cited by
- 265
- References
- 249
- FWCI
- 51.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.